| Dr. Arun Raturi has over 15 years of biopharma industry experience developing, characterizing, and manufacturing pharmaceutics and biologics. He is the lead researcher in the development and validation of Entos' Fusogenix PLV platform and the inventor of key Entos intellectual property for drug delivery. Dr. Raturi developed fluorogenic-chromogenic screening and neutralizing assays as well as cell-based assays for cancer drugs with biopharmaceutical companies. Dr. Raturi trained at The Scripps Research Institute and received a Ph.D. in biochemistry from the University of Windsor. |
